Copyright
©The Author(s) 2021.
World J Crit Care Med. Sep 9, 2021; 10(5): 244-259
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.244
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.244
Table 6 Propensity score adjusted Cox proportional hazards analysis of independent predictors of survival in intensive care unit patients with coronavirus disease 2019
| B | SE | P value | HR | 95%CI | |
| Age | 0.03 | 0.007 | < 0.001 | 1.031 | 1.02-1.05 |
| Sex (male) | 0.41 | 0.2 | 0.038 | 1.51 | 1.022-2.22 |
| Vasopressors | 0.47 | 0.23 | 0.019 | 1.6 | 1.081-2.37 |
| GC + Tocilizumab | -0.78 | 0.22 | 0.001 | 0.46 | 0.29-0.72 |
| GC only | -0.44 | 0.22 | 0.048 | 0.65 | 0.42-0.99 |
- Citation: Iglesias JI, Vassallo AV, Sullivan JB, Elbaga Y, Patel VV, Patel N, Ayad L, Benson P, Pittiglio M, Gobran E, Clark A, Khan W, Damalas K, Mohan R, Singh SP. Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital. World J Crit Care Med 2021; 10(5): 244-259
- URL: https://www.wjgnet.com/2220-3141/full/v10/i5/244.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i5.244